Mary Bussell, CEO at TriMar Strategies, shared a post on LinkedIn about a recent article she and her colleagues co-authored, adding:
“Delighted to share our article in the European Journal of Cancer, Bridging the Gap in Lung Cancer: A Comprehensive Global Strategy for Change, providing the global evidence and policy rationale underpinning the Lung Cancer Consensus Statement
I extend sincere thanks to the 21 organizations worldwide endorsing the Lung Cancer Consensus Statement: Bridging the Gap in the Diagnosis and Management of Lung Cancer
- Hellenic Association of Lung Cancer-HeALC (Ελληνική Εταιρεία Καρκίνου Πνεύμονα-ΕΛΕΚΑΠ)
- American Medical Women’s Association | AMWA
- Biomarker Collaborative
- Canadian Lung Cancer Advocacy
- Cancer Patients Europe
- Exon20 Group
- Hellenic Cancer Federation | ELLOK
- FairLife Lung Cancer Care
- Institute of Cancer and Crisis
- International Cancer Advocacy Network | ICAN
- Kenyan Network of Cancer Organizations | KENCO
- Lung Health Foundation
- Lung Cancer Europe | LuCE
- Lung Cancer Network Malaysia
- Lung Cancer Research Foundation
- LUNGevity Foundation
- Mathiwos Wondu – YeEthiopia Cancer Society
- MET Crusaders
- Oncology Advocates United for Climate and Health – International United for Climate and Health | OUCH
- PDL1 Amplifieds
- STEMM and Cancer Health Equity | SCHEQ
Their endorsement sends a powerful signal that lung cancer requires sustained political leadership, policy coherence, and coordinated action across the full continuum, from prevention and early detection to diagnosis, treatment, survivorship and destigmatization
In 2026, TriMar Strategies, grateful for support from Merck, will explicitly bring lung cancer into dialogue with finance and economic decision-makers. Addressing lung cancer in financially sustainable ways requires meaningful engagement with Ministries of Finance in partnership with Ministries of Health to ensure that investments in prevention, early detection, diagnostics and effective treatments are understood not as costs, but as essential components of national health security, economic resilience and long-term development
In this context, strengthening lung cancer policy is not solely a health imperative. It is integral to safeguarding populations, protecting productivity and reinforcing the resilience of health systems in the face of demographic change, environmental pressures and future shocks
We invite additional organizations around the world to join us in our efforts to build awareness, strategically align, improve access, catalyze action and strengthen accountability – ensuring that lung cancer is firmly embedded within national and global health, development and financing agendas where it belongs.”
Title: Bridging the gap in lung cancer: A comprehensive global strategy for change
Authors: Kostas N. Syrigos, Mary E. Bussell, Humaid O. Al-Shamsi, Ola Khorshid, Roy S. Herbst, Sofia Agelaki, Natasha Leighl, Fred Hirsch, Heather Wakelee
Read the Full Article on European Journal of Cancer
More posts featuring Mary Bussell.